inflamed pharma
PrivateLast Round
Grant
Mar 23, 2020
Company Overview
inflamed pharma is a biotechnology company that provides a patented technology platform, JenCluTec®, to increase the water solubility and membrane permeability of small molecules.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
inflamed pharma Comparables
Compare inflamed pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zerion Pharma | 86% | |
| Harpago | 82% | |
| AustinPx | 79% | |
inflamed pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 23, 2020 |
inflamed pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Regional Development Fund | Grant |
| Xlife Sciences AG | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2020
Received grant funding from the European Regional Development Fund.
inflamed pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about inflamed pharma's valuation, stock price, and market status.